Associations Between Multiple Circulating Biomarkers and the Presence of Atrial Fibrillation in Hypertrophic Cardiomyopathy with or Without Left Ventricular Outflow Tract Obstruction-Reference-Cited by-同舟云学术

Associations Between Multiple Circulating Biomarkers and the Presence of Atrial Fibrillation in Hypertrophic Cardiomyopathy with or Without Left Ventricular Outflow Tract Obstruction

Published:2019-03-30 Issue:2 Volume:60 Page:327-335
ISSN:1349-2365
Container-title:International Heart Journal
language:en
Short-container-title:Int. Heart J.

Author:

Liu Limin¹,Wu Lingmin¹,Zheng Lihui¹,Ding Ligang¹,Chen Gang¹,Fan Xiaohan¹,Yao Yan¹

Affiliation:

1. Clinical EP Lab & Arrhythmia Center, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College

Publisher

International Heart Journal (Japanese Heart Journal)

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/ihj/60/2/60_18-438/_pdf

Reference35 articles.

1. 1. Yoshinaga M, Yoshikawa D, Ishii H, et al. Clinical characteristics and long-term outcomes of hypertrophic cardiomyopathy. Int Heart J 2015; 56: 415-20.

2. 2. Mano T. HCM. Int Heart J 2018; 59: 243-4.

3. 3. Guttmann OP, Rahman MS, O'Mahony C, Anastasakis A, Elliott PM. Atrial fibrillation and thromboembolism in patients with hypertrophic cardiomyopathy: systematic review. Heart 2014; 100: 465-72.

4. 4. Olivotto I, Cecchi F, Casey SA, Dolara A, Traverse JH, Maron BJ. Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy. Circulation 2001; 104: 2517-24.

5. 5. Olivotto I, Maron BJ, Cecchi F. Clinical significance of atrial fibrillation in hypertrophic cardiomyopathy. Curr Cardiol Rep 2001; 3: 141-6.

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From Atrial Fibrillation Management to Atrial Myopathy Assessment: The Evolving Concept of Left Atrium Disease in Hypertrophic Cardiomyopathy;Canadian Journal of Cardiology;2024-05

2. Circulating Biomarkers in Hypertrophic Cardiomyopathy;Journal of the American Heart Association;2022-12-06

3. Alteration of serum biomarkers in patients with hypertrophic cardiomyopathy with and without atrial fibrillation;Biomarkers in Medicine;2021-09

4. Pericardial NT-Pro-BNP and GDF-15 as Biomarkers of Atrial Fibrillation and Atrial Matrix Remodeling in Aortic Stenosis;Diagnostics;2021-08-05

5. Outcome of alcohol septal ablation in mildly symptomatic patients with hypertrophic obstructive cardiomyopathy: A comparison with medical therapy;Clinical Cardiology;2021-07-24